ACSS2 and neoplasm: In cervical squamous cell carcinoma (CESC), ACSS2 upregulation fosters an immunosuppressive TIME by enhancing cancer-associated fibroblast (CAF) exhaustion and Treg activity, promoting tumor invasion and metastasis.